Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota. β
Go to Publication β
Food & function (Food Funct ) Vol: 8 Issue 12 Pages: 4644-4656 Pub: 2017 Dec 13 Epub: Authors Zhao L , Zhang Q , Ma W , Tian F , Shen H , Zhou M , |
|
|
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-?B Axis. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 679897 Pub: 2021 Epub: 2021 Jul 22 Authors Qu Y , Li X , Xu F , Zhao S , Wu X , Wang Y , Xie J , |
|
|
Antitumor Effect and Gut Microbiota Modulation by Quercetin, Luteolin, and Xanthohumol in a Rat Model for Colorectal Cancer Prevention. β
Go to Publication β
Nutrients (Nutrients ) Vol: 16 Issue 8 Pages: Pub: 2024 Apr 13 Epub: 2024 Apr 13 Authors Pérez-Valero Á , Magadán-Corpas P , Ye S , Serna-Diestro J , Sordon S , Huszcza E , Poplonski J , Villar CJ , Lombó F , |
|
|
Antitumor Effect and Gut Microbiota Modulation by Quercetin, Luteolin, and Xanthohumol in a Rat Model for Colorectal Cancer Prevention. β
Go to Publication β
Nutrients (Nutrients ) Vol: 16 Issue 8 Pages: Pub: 2024 Apr 13 Epub: 2024 Apr 13 Authors Pérez-Valero Á , Magadán-Corpas P , Ye S , Serna-Diestro J , Sordon S , Huszcza E , Poplonski J , Villar CJ , Lombó F , |
|
|
Antitumor Effect and Gut Microbiota Modulation by Quercetin, Luteolin, and Xanthohumol in a Rat Model for Colorectal Cancer Prevention. β
Go to Publication β
Nutrients (Nutrients ) Vol: 16 Issue 8 Pages: Pub: 2024 Apr 13 Epub: 2024 Apr 13 Authors Pérez-Valero Á , Magadán-Corpas P , Ye S , Serna-Diestro J , Sordon S , Huszcza E , Poplonski J , Villar CJ , Lombó F , |
|
|
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. β
Go to Publication β
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , |
|
|
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. β
Go to Publication β
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , |
|
|
Effect of grape pomace supplement on growth performance, gastrointestinal microbiota, and methane production in Tan lambs. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1264840 Pub: 2023 Epub: 2023 Sep 28 Authors Cheng X , Du X , Liang Y , Degen AA , Wu X , Ji K , Gao Q , Xin G , Cong H , Yang G , |
|
|
Effect of grape pomace supplement on growth performance, gastrointestinal microbiota, and methane production in Tan lambs. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1264840 Pub: 2023 Epub: 2023 Sep 28 Authors Cheng X , Du X , Liang Y , Degen AA , Wu X , Ji K , Gao Q , Xin G , Cong H , Yang G , |
|
|
Quercetin modulates the gut microbiota as well as the metabolome in a rat model of osteoarthritis. β
Go to Publication β
Bioengineered (Bioengineered ) Vol: 12 Issue 1 Pages: 6240-6250 Pub: 2021 Dec Epub: Authors Lan H , Hong W , Qian D , Peng F , Li H , Liang C , Du M , Gu J , Mai J , Bai B , Peng G , |
|
|
Quercetin reshapes gut microbiota homeostasis and modulates brain metabolic profile to regulate depression-like behaviors induced by CUMS in rats. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1362464 Pub: 2024 Epub: 2024 Mar 26 Authors Li B , Yan Y , Zhang T , Xu H , Wu X , Yao G , Li X , Yan C , Wu LL , |
|
|
Quercetin alleviates intestinal inflammation and improves intestinal functions via modulating gut microbiota composition in LPS-challenged laying hens. β
Go to Publication β
Poultry science (Poult Sci ) Vol: 102 Issue 3 Pages: 102433 Pub: 2023 Mar Epub: 2022 Dec 16 Authors Feng J , Li Z , Ma H , Yue Y , Hao K , Li J , Xiang Y , Min Y , |
|
|
Quercetin reduces atherosclerotic lesions by altering the gut microbiota and reducing atherogenic lipid metabolites. β
Go to Publication β
Journal of applied microbiology (J Appl Microbiol ) Vol: 127 Issue 6 Pages: 1824-1834 Pub: 2019 Dec Epub: 2019 Oct 7 Authors Nie J , Zhang L , Zhao G , Du X , |
|
|
Quercetin metabolism by fecal microbiota from healthy elderly human subjects. β
Go to Publication β
PloS one (PLoS One ) Vol: 12 Issue 11 Pages: e0188271 Pub: 2017 Epub: 2017 Nov 27 Authors Tamura M , Hoshi C , Kobori M , Takahashi S , Tomita J , Nishimura M , Nishihira J , |
|
|
Quercetin metabolism by fecal microbiota from healthy elderly human subjects. β
Go to Publication β
PloS one (PLoS One ) Vol: 12 Issue 11 Pages: e0188271 Pub: 2017 Epub: 2017 Nov 27 Authors Tamura M , Hoshi C , Kobori M , Takahashi S , Tomita J , Nishimura M , Nishihira J , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
